Abstract: A composition contains 2 to 6 parts by weight of at least one rhamnolipid, 1 to 4 parts by weight of at least one alkyl polyglycoside, and 1 to 3 parts by weight of at least one acyl lactylate.

Abstract: A composition contains glycolipids and Methyl citrate (TEC). The TEC can assist in stabilizing a foam of a corresponding aqueous composition. A method can be used for preparing a corresponding formulation, preferably a cosmetical or pharmaceutical formulation, by providing the composition and diluting the composition.

Abstract: The invention relates to compositions comprising glycolipids and benzoic acid and/or sorbic acid.

Abstract: A process can be used for the enzymatic preparation of sugar esters and/or sugar alcohol esters. Mixture compositions contain the sugar esters and/or sugar alcohol esters.

Abstract: Xylitol carboxylates are products of interest in the food and cosmetics industries. A process can be used for the enzymatic preparation of xylitol carboxylates.

Abstract: A process can be used for enzymatic preparation of sorbitan carboxylates. Sorbitan carboxylates are obtainable by this process.

Abstract: The present invention relates to oral care compositions comprising at least one biosurfactant and fluoride.

Abstract: The present invention relates to a process for producing an esterquat by a transesterification reaction of a fatty acid oil or a mixture comprising one or more fatty acid oils and one or more fatty acids with a tertiary hydroxy amine and then a quaternization reaction. Esterquats obtained by the method of the invention show beneficial properties in particular when used as active component in fabric softener materials.

Abstract: The present invention relates to at least one cell for producing at least one lipid with general formula II from at least one carbon substrate, wherein R1 and R2 independently of one another comprises identical or different organic radicals each with 5 to 13 carbon atoms, wherein the cell is a non-pathogenic cell that is genetically modified to increase the heterologous expression relative to the wild type cell of: an enzyme (E2) capable of converting 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP or 3-(3-hydroxyalkanoyloxy)alkanoic acid (HAA) and NDP-glucose into ?-D-glucopyranosyl-3-hydroxyalkanoyl-3-hydroxyalkanoate.

Abstract: The invention provides a process for preparing sphingolipids, compositions comprising sphingolipids and further components, and for the use of the compositions.

Abstract: The present invention relates to a process for producing an esterquat by a transesterification reaction of a fatty acid oil or a mixture comprising one or more fatty acid oils and one or more fatty acids with a tertiary hydroxy amine and then a quaternization reaction. Esterquats obtained by the method of the invention show beneficial properties in particular when used as active component in fabric softener materials.

Abstract: The invention relates to a mixture composition comprising glucolipids, to its use for producing formulations and to formulations comprising this mixture composition.

Abstract: The invention relates to compositions comprising glycolipids and benzoic acid and/or sorbic acid.

Abstract: The invention provides a process for preparing sphingolipids, compositions comprising sphingolipids and further components, and for the use of the compositions.

Abstract: The invention relates to compositions comprising at least one protease and at least one biosurfactant, particularly selected from rhamnolipids and sophorolipids. In particular, the present invention is directed to a composition including A) at least one peptidase, B) at least one biosurfactant, and optionally C) at least one anionic surfactant. The peptidase may be selected from the group of the proteases, particularly from the group of the serine proteases of EC 3.4.21 and the metalloproteases of EC 3.4.24 and the biosurfactant may be selected from the group comprising rhamnolipids and sophorolipids.

Abstract: The invention provides derivatives of rhamnolipids, formulations comprising these, and the use thereof.

Abstract: The present invention relates to at least one cell for producing at least one lipid with general formula II from at least one carbon substrate, wherein R1 and R2 independently of one another comprises identical or different organic radicals each with 5 to 13 carbon atoms, wherein the cell is a non-pathogenic cell that is genetically modified to increase the heterologous expression relative to the wild type cell of: an enzyme (E2) capable of converting 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP or 3-(3-hydroxyalkanoyloxy)alkanoic acid (HAA) and NDP-glucose into ?-D-glucopyranosyl-3-hydroxyalkanoyl-3-hydroxyalkanoate.

Abstract: The invention relates to cosmetic formulations comprising specific ester quats based on isopropanolamine or tetrahydroxypropyl ethylenediamine, and to the use of these ester quats in cosmetics.

Abstract: The invention relates to a dispersion containing at least one rhamnolipid derivative and also to the use of the rhamnolipid derivatives as emulsifier or dispersing aid.

Abstract: The invention relates to the use of polyolethers as additives in aqueous polymer dispersions for producing porous polymer coatings, preferably for producing porous polyurethane coatings.